pneumonia

Stomach acid reducer increases risk of pneumonia

harminka — Mon, 14 Sep 2009 11:36:38 -0500

A popular stomach-acid reducer used to prevent stress ulcers in critically ill patients needing breathing machine support increases the risk of those patients contracting pneumonia threefold, according to researchers at Wake Forest University School of Medicine.

New vaccine may improve COPD in patients at risk for pneumonia

harminka — Tue, 08 Sep 2009 02:04:50 -0500

A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic Society.

Risk factors identified for pneumonia after heart surgery

harminka — Thu, 30 Apr 2009 02:25:50 -0500

Ventilator-associated pneumonia (VAP) is the main cause of nosocomial infection in patients undergoing major heart surgery. An international study of 25 hospitals from 8 European countries, published in BioMed Central's open access journal Critical Care, has confirmed the degree of danger posed by VAP and identified the main risk factors.

Protein from Staph Infection Causes Lung Injury in Pneumonia

harminka — Thu, 22 Jan 2009 02:49:07 -0600

Researchers led by Dr. Pyong Woo Park at Children's Hospital, Harvard Medical School found that Staphlococcus aureus & beta toxin causes lung injury in pneumonia. They report their findings in the February 2009 issue of The American Journal of Pathology.

Pneumococcal vaccine does not appear to protect against pneumonia

harminka — Tue, 06 Jan 2009 03:37:29 -0600

Commonly used pneumococcal polysaccharide vaccines do not appear to be effective for preventing pneumonia, found a study by a team of researchers from Switzerland and the United Kingdom.

Toothbrushing can prevent hospital-borne pneumonia

harminka — Thu, 11 Dec 2008 12:11:39 -0600

Hospital-borne infections are a serious risk of a long-term hospital stay, and ventilator-associated pneumonia (VAP), a lung infection that develops in about 15% of all people who are ventilated, is among the most dangerous.

Use of inhaled corticosteroids for COPD does not appear to improve survival

harminka — Wed, 26 Nov 2008 14:20:52 -0600

An analysis of randomized trials indicates that use of inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease (COPD) does not improve the rate of survival after one year, but is associated with an increased risk of pneumonia, according to an article in the November 26 issue of JAMA.

Model against unnecessary use of antibiotics

harminka — Wed, 15 Oct 2008 11:52:55 -0500

Antibiotic treatment for pneumonia in intensive care ‘to be on the safe side’ no longer necessary

Steroids aid recovery from pneumonia

harminka — Wed, 15 Oct 2008 08:26:43 -0500

Adding corticosteroids to traditional antimicrobial therapy might help people with pneumonia recover more quickly than with antibiotics alone, UT Southwestern Medical Center scientists have found.

Stick with simple antibiotics for pneumonia to avoid super bugs

harminka — Tue, 26 Aug 2008 13:25:25 -0500

Australian hospitals should avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs, according to a University of Melbourne study.

Vaccinated infants protected against severe pneumococcal infection in Norway

harminka — Thu, 10 Jul 2008 08:19:46 -0500

In 2006, a pneumococcal vaccine (Prevenar®) was introduced in the childhood vaccination programme in Norway. Two years later, the experiences have been published in the journal Vaccine. The results show a strong decline in serious pneumococcal infections among young children.

Public should not get complacent about pneumococcal disease

harminka — Tue, 03 Jun 2008 11:42:52 -0500

Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.